The Keio Journal of Medicine
Online ISSN : 1880-1293
Print ISSN : 0022-9717
REVIEW
Advances in Genomic Research on Hepatitis C Virus with a Useful Tool, Replicon System
Mitsuyasu NakamuraHidetsugu SaitoToshifumi Hibi
Author information
JOURNALS FREE ACCESS

Volume 57 (2008) Issue 2 Pages 75-83

Details
Download PDF (560K) Contact us
Abstract

The research for hepatitis C virus (HCV) has long delayed by missing of in vitro culture system. Since the development of replicon system, a replication system of subgenomic HCV RNAs in a hepatoma cell line, has been reported, many virological and clinical findings have been discovered. Recently, in addition of subgenomic replication system, hepatitis C virus full-length RNA replication has been possible, and a few cell culture systems producing viral particles have been produced. These developments enabled us to investigate the life cycle or intracellular circumstance of HCV production. By screening of newly synthesized drugs with this replicon system, several possible medicines have been established and clinical researches are now running. Among them, VX950 and SCH503034 are nearest to clinical use. Other possible agents for reducing viral replication such as cyclophyllin inhibitors, inhibitors of sphingomyelin synthesis, HMG-CoA reductase inhibitors, or RNA-dependent RNA polymerase inhibitors have been also investigated. Furthermore the mechanism for development of hepatocellular carcinoma in the HCV infected liver has been vigorously studied using the HCV replicon system.

Information related to the author
© 2008 by The Keio Journal of Medicine
Next article

Recently visited articles
feedback
Top